Page 4 - Cue Reader News Today

The nucleic acid amplification test returns results in 25 minutes and is authorized for use in professional point-of-care settings. 

Operator: Good day, and thank you for standing by. Welcome to the Cue Health Fourth Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. .

/PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that...

COVID-19 drove an investment boom that pushed diagnostics innovation, but newer technologies could be in a precarious position as public funding and test sales slow.

SAN DIEGO, Sept. 1, 2022 /PRNewswire/ -- Cue Health (Cue) (Nasdaq: HLTH) today announced that it has made a de novo submission to the U.S. Food ...

Accelerate Diagnostics (NASDAQ:AXDX – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Insider and Institutional Ownership 65.5% of Accelerate Diagnostics shares […]

Coherent (NASDAQ:COHR – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Coherent and Cue […]

While most people are familiar with rapid at-home antigen tests, Cue Health, Detect, and Lucira Health all have FDA-authorized OTC molecular tests that combine PCR accuracy with the convenience of at-home antigen tests.

Cue Health (NASDAQ:HLTH – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, […]

Cue Health (NASDAQ:HLTH – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Profitability This table compares Cue Health and Codex DNA’s […]